Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Psyched Wellness ( (TSE:PSYC) ) has provided an update.
Psyched Wellness has launched ‘Calmer,’ a new product that offers twice the potency of its flagship product, ‘Calm,’ and has improved the flavor profile of ‘Calm’ to reduce the mushroom taste. This launch is part of a broader strategy to expand market partnerships in Canada and the United States, and coincides with a Black Friday promotion offering significant discounts. The introduction of ‘Calmer’ and the flavor enhancement of ‘Calm’ are expected to strengthen Psyched Wellness’s position in the dietary supplements industry by addressing consumer feedback and enhancing product appeal.
Spark’s Take on TSE:PSYC Stock
According to Spark, TipRanks’ AI Analyst, TSE:PSYC is a Neutral.
Psyched Wellness presents a complex investment case. While the company shows promising revenue growth and a stable equity position, its ongoing profitability challenges and negative valuation metrics weigh heavily on its overall score. Technical analysis suggests a bearish trend, further compounded by valuation concerns. However, strategic corporate events provide a glimpse of potential future upside, reflecting a modestly positive outlook.
To see Spark’s full report on TSE:PSYC stock, click here.
More about Psyched Wellness
Psyched Wellness Ltd. is a Canadian-based life sciences company focused on researching and producing dietary supplements derived from the Amanita Muscaria mushroom. The company specializes in consumer packaged goods products utilizing its proprietary extract, AME-1, and targets the dietary supplements market.
Average Trading Volume: 111,666
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$5.78M
For a thorough assessment of PSYC stock, go to TipRanks’ Stock Analysis page.